KETOPROFENE/OMEPRAZOLE MEDIPHA 200 mg/20 mg, modified-release capsule 14 capsules
Active ingredients: KÉTOPROFÈNE, Omeprazole
Commercialized according to BDPMDispensing in France: Prescription only
Modified-release capsule14 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KETOPROFENE/OMEPRAZOLE MEDIPHA 200 mg/20 mg, gélule à libération modifiée
- Pharmaceutical form
- gélule à libération modifiée
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 14 gélule(s) ( abrogée le 25/11/2022)
- Marketing authorisation holder
- MEDIPHA SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 13 Sept 2018
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66433778CIP73957313CIP133400939573137Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| KÉTOPROFÈNEgélule | 200 mg · une gélule | SA |
| OMÉPRAZOLEgélule | 20 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.